Characterization of Macroprolactinemia

Status Completed

Clinical Trial Summary

The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed.

We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.

Clinical Trial Description

n/a

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Hyperprolactinemia

Clinical Trial Details

NCT number	NCT00436111
Study type	Observational
Source	Kansai Medical University
Contact
Status	Completed
Phase	N/A
Start date	January 2005
Completion date	December 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03569787` - Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
Completed	`NCT02098668` - Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON	N/A
Completed	`NCT03038308` - Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole	Phase 1/Phase 2
Not yet recruiting	`NCT00541554` - Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia	Phase 4
Completed	`NCT01270711` - Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)	N/A
Completed	`NCT02956447` - Administration of Kisspeptin in Patients With Hyperprolactinemia	Phase 2
Recruiting	`NCT05033119` - PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
Completed	`NCT06326840` - Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment	N/A
Withdrawn	`NCT00699530` - Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment	N/A
Not yet recruiting	`NCT00315081` - Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine	Phase 3
Recruiting	`NCT04746313` - Prevalence of Hyperprolactinemia in Systemic Scleroderma
Terminated	`NCT04146389` - Hyperprolactinemia and Adrenal Steroidogenesis
Recruiting	`NCT00914823` - Kisspeptin Administration in the Adult	Phase 1
Suspended	`NCT02603549` - Pituitary Function and Spontaneous Intracranial Hypotension
Completed	`NCT01852331` - Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia	Phase 2
Completed	`NCT01338298` - Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia	N/A
Completed	`NCT01052948` - The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events	N/A
Active, not recruiting	`NCT04439747` - Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease
Recruiting	`NCT01742390` - A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders	Phase 4
Completed	`NCT00625950` - Endometriosis Patients Undergoing Quinagolide Treatment	Phase 4